KROS stock results show that Keros Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. More
Articles
INDP Stock Earnings: Indaptus Therapeutics Misses EPS for Q1 2024
INDP stock results show that Indaptus Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. More
TGNA Stock Earnings: Tegna Beats EPS, Misses Revenue for Q1 2024
TGNA stock results show that Tegna beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
HFFG Stock Earnings: HF Foods Group Reported Results for Q1 2024
HF Foods Group just reported results for the first quarter of 2024. More
RIVN Stock Alert: Rivian Raises Demand Concerns With Weak Production Forecast
RIVN stock is sinking lower after the company provided 2024 production guidance of 57,000, signaling no growth compared to 2023. More
SMRT Stock Earnings: SmartRent Misses EPS, Misses Revenue for Q1 2024
SMRT stock results show that SmartRent missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
